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ABSTRACT: 
AIM: To analyse the  visual outcome &  complications in secondary intraocular 
lens implantation. 
METHODS: A prospective clinical study was done in 30 aphakic patients who 
underwent secondary intraocular lens implantation in the posterior chamber. 17 
patients had total absence  of capsular remnants and underwent scleral fixation 
intraocular lens implantation. 10 patients had partial capsular remnants and they 
underwent ciliary sulcus fixation intraocular lens implantation. 3 patients had intact 
posterior capsule and underwent in the bag posterior chamber intraocular lens 
implantation. These patents were followed up for 6 weeks post operatively. 
RESULTS: 83% of patients had BCVA of 6/9 and above after 6 weeks 
postoperatively.  3% of patients had BCVA of 6/24 and 13% of patients developed 
BCVA 6/36 and less. Minor complications like striate keratopathy, corneal  
oedema and anterior uveitis was seen and subsided with treatment. 1 patient had 
hyphema which results spontaneously. 1 patient had increased intraocular pressure 
for 1 week and was controlled with anti-glaucoma medications. 1 patient had 
persistent corneal oedema, 2 patients developed cystoid macular oedema and 1 
patient developed retinal detachment. 
CONCLUSION: Secondary intraocular lens implantation in the posterior chamber 
is a safe and effective method of correcting aphakia and avoids the disadvantages 
associated with aphakic spectacles and contact lens. 
 INTRODUCTION 
Secondary intraocular lens implantation refers to intraocular lens 
insertion at a time remote from the initial cataract extraction (or less commonly, 
from the trauma that led to the loss of the lens).1 
Cataract is the commonest age related disease in most countries 
worldwide. There are approximately 45 million blind people in the world. At 
least 80% of these people live in developing countries and more than half are 
blind as a result of cataract.2It is estimated that in India alone, more than 5.1 
million patients undergo cataract surgery in a year.3 
There are a variety of cataract extraction methods, including phaco-
emulsification, extracapsular cataract extraction and intracapsular cataract 
extraction.4 
The intracapsular method of cataract extraction was the preferred 
technique for nearly 50 years. However, the momentum shift towards ECCE 
probably began in 1967.5 
In intracapsular cataract extraction (ICCE), the lens is removed along 
with the capsule and in Extracapsular cataract extraction (ECCE), posterior 
capsule is spared.6Since 1970, phacoemulsification and extracapsular cataract 
surgery have replaced intracapsular cataract , except for rare instances, such as 
subluxated lenses or eyes in which a question of patient sensitivity to lens 
material exists.7However placement of a posterior chamber intraocular lens may 
 not be possible in all eyes that undergo this procedure, due to unforeseen 
complications that may occur intraoperatively.3 
Modern cataract surgery involves phacoemulsification of the opacified 
crystalline lens and the implant of an intraocular lens (IOL) in the capsular bag. 
In some conditions this is not possible due to the type of cataract (e.g., traumatic 
cataracts with lens subluxation, cataracts in pseudoexfoliative syndrome with 
zonular/capsular dehiscence) or to systemic and congenital disorders 
characterized by weakness of zonules/capsule (e.g., familial or idiopathic 
ectopia lentis, Marfan syndrome, etc.) or to intraoperative complications (e.g., 
large breaks of the posterior capsule, accidental aspiration of the capsular bag, 
etc.) leaving the patient aphakic.8 
Aphakia can be corrected by either spectacle lens, contact lens or 
intraocular lens. The insertion of an intraocular lens within the aphakic eye 
overcomes the optical disadvantages of aphakic spectacles and the handling and 
wearing difficulties encountered with contact lens.9, 10 
An IOL can be placed in the anterior chamber between the cornea and 
iris, as in iris-fixated and closed- or open-loop anterior chamber IOLs (AC 
IOLs), or it can be implanted in the posterior chamber within the ciliary sulcus 
posterior to the iris, as in sutured iris-fixated and sclera fixated posterior 
chamber IOLs (PC IOLs).11 
 The preferred lens for aphakic rehabilitation is a posterior chamber lens. 
Major therapeutic advantages of a posterior chamber IOL over anterior chamber 
IOL are 
1.
 A PCIOL is closer to the focal point of the eye reducing the image 
magnification. 
2.
 Its position away from delicate anterior chamber structures especially the 
corneal endothelium and anterior chamber angle. 
3. The risk of CME, glaucoma and corneal oedema is lower with 
PCIOLs12,13 
This study is done to analyse the secondary intraocular lens implantation in 
the posterior chamber.  
 REVIEW OF LITERATURE 
Secondary intraocular lens implantation is defined as insertion of an IOL 
into an eye which is rendered aphakic by prior cataract extraction by any 
method, or by an exchange of IOL, which is a special case of secondary IOL 
implantation.20 
INDICATIONS 
1. Monocular aphakia 
a. Spectacle or contact lens intolerance 
b. Old and disabled persons with Parkinsonism, tremor and other 
physical disability which makes handling and using of spectacle or 
contact lens difficult. 
c. Occupational and circumstantial situations where spectacle or contact 
lens is not suitable or cumbersome, e.g. athletes, dancers, etc. 
2. Contralateral pseudophakia 
a. Aborted primary IOL implantation 
b. Bilateral aphakia in children  
c. Corneal decompensation due to ACIOL 
d. In combination with other procedures like pars plana lensectomy for 
dislocated crystalline lens treatment, penetrating keratoplasty, or 
trabeculectomy. 
 HISTORY OF INTRAOCULAR LENS IMPLANTS: 
In early 18th century there have been abortive attempts of IOL 
implantation. 
The modern era began with observations made during World War II. The 
apparent lack of reactions to PMMA fragments in eyes of fighter pilots was 
impressive.15 
In 1949, Ridley implanted his first PMMA IOL in a 45 year old woman 
into the posterior chamber of the eye after ECCE.21 The long term results of this 
IOL was disappointing because of downward decentration, anterior dislocation 
and posterior dislocation. 
Anterior chamber angle fixated lenses were designed because of 
difficulties encountered with Ridley’s posterior chamber lenses. On May 13, 
1952 Baron’s modified ACIOL was implanted by Strampelli.22 Several 
modifications were made to decrease the complications associated with 
ACIOLs. 
Anterior chamber IOLs were easy to insert but it demanded correct sizing 
and positioning so that haptics rested at the sclera spur. 
Epstein & Binkhorst revised lens implant surgery by developing iris 
fixation lenses. In 1957 Binkhorst developed iris clip lens and implanted on 
August, 11 1958. 23, 24 
 This was usually used with an ICCE and later variations were made in the 
shape, length, and insertion of the haptic loops. 
The iris clip lens prevents fixation in the chamber angle & in the posterior 
chamber. Thus the complications of corneal damage with ACIOL and 
possibility of dislocation with positioning of implant behind the iris was 
lessened.25 
Modifications of iris clip lens were made by Fyodorov and Copeland in 
1964 and 1968 respectively.27 
In 1969, Worst sutured one of the anterior loops of the iris to prevent 
dislocation of iris clip lens. Binkhorst placed the iris-clip lens vertically rather 
than in horizontal position in 1970. Variations in iris fixated lens were also 
made to overcome the complications.22 
It was realised that an extracapsular cataract extraction would yield better 
results than intracapsular extraction by Binkhorst work. 
Pearce in England demonstrated the feasibility of posterior chamber 
fixation. In 1977 he sutured a 4mm optic tripod suture to iris for secondary 
fixation. 
Sherring in 1978 designed J-loop posterior chamber lens which was a 
modification of Barraquer anterior chamber lens.25 This could be fixated in the 
 capsular bag or ciliary sulcus and provided lowest complication rate. A series of 
modifications of the original shearing lens was made with PMMA optics. 
The optic material of the original Ridley lens is still used in most IOLs 
usually. This is made up of poly methylmethacrylate (PMMA). 
PMMA is inert and well tolerated with in the eye. It is a light, durable 
material with a specific gravity of 1.19 and refractive index of 1.49.28 
The most important change in design is in the introduction of single- 
piece PMMA lenses. There is no loop optic junction thus decreasing the risk for 
adherence of inflammatory cells. The flexibility of PMMA lens increase by 
increasing the loop length. Thus making it easier during implantation of the 
loop and decreasing the possibility of breaking the loop during handling. 
The most important advantage of a single piece PMMA lens is its ability 
to achieve excellent centration. 
 
 
 
 
 
 
 CORRECTION OF APHAKIA 
The natural crystalline convex lens of the eye has an effective power of 
approximately +20dioptres. Removal of the cataractous lens therefore leaves the 
eye with a large refractive error. 
There are 3 options for correction of aphakia 
1. Spectacle lens 
2. Contact lens 
3. Intraocular lens14 
Spectacle lens 
Spectacle lenses were better accepted 50 years ago than today as no other 
method of optic correction was available15. All spectacle wearers have to 
contend with several problems due to high refractive power of the lens required 
(approx. +10D or more). 
The relative spectacle magnification (RSM) produced by aphakic 
spectacle correction is approximately 1.33. This means that the image produced 
in the corrected aphakic eye is one third (25 to 30%) larger than the image 
formed in emmetropic eye. This magnification causes the patient to misjudge 
distances. Objects appear to be closer to the eye than they really are because of 
the increased visual angle subtended at the eye.14 
 Spectacle correction in unilateral aphakic eye can achieve a clear retinal 
image, but with a relative spectacle magnification of 1.33 the image in the 
aphakic eye is one third larger than the image in the normal fellow eye. The 
patient is unable to fuse images of such unequal size (aniesokonia) and 
complains of seeing double.14 
The lenses used in aphakic spectacles are subject to the aberrations. In 
particular, image distortion is very troublesome to the newly aphakic patient. 
Straight lines appear curved (pin cushion effect).29 
The prismatic effect of aphakic spectacle lenses produces a ring scotoma 
all around the edge of the lens causing the patient to trip over unseen 
obstruction in their path.29, 30 
These high powered lenses are heavy and uncomfortable to wear. 
The foregoing aberrations and prismatic effects can be eliminated by 
contact lens or intraocular lens implant. 
Contact lens 
Linksz cited the following advantages 
1. No significant magnification (only 7%) 
2. No appreciable spherical aberration, no pin cushion distortion 
3. No ring scotoma, no jack in the box phenomenon and full peripheral 
vision31 
 Contact lens is more practical in young aphakic patients than in elderly. 
The main disadvantage in most elderly patients is they do not possess the 
manual dexterity to insert and remove them.15 
Intra ocular lens 
The insertion of an intraocular lens within the aphakic eye overcomes the 
optical disadvantages of aphakic spectacles and the handling and wearing 
difficulties encountered with contact lenses. The IOL becomes part of the 
optical system of the eye, and because it is situated at or very close to the 
position of crystalline lens, problems with RSM do not arise.14 
 
 
 
 
 
 
 
 
 
 CLASSIFICATION OF SECONDARY INTRAOCULAR LENSES 
The four principal alternatives for fixation of secondary IOLs: 
1. Standard capsular bag-fixated or sulcus-fixated posterior chamber(PC) 
lenses 
2. Transscleral suture-fixated PC lenses 
3. Peripheral iris suture-fixated PC IOLs 
4. Anterior chamber (AC) lenses.16 
If capsular support is available standard PC lenses placed in the ciliary 
sulcus or, preferably, in the capsular bag are the standard of care. If capsular 
support is absent, three primary options exist for IOL fixation in the absence of 
capsular support: transscleral-sutured PC IOLs, peripheral iris sutured PC IOLs 
and flexible open-loop ACIOLs.15 
 
 
 
 
 
 
 
 
 
 POSTERIOR CHAMBER INTRAOCULAR LENSES 
The posterior chamber is the normal anatomic position of crystalline lens. 
Thus the ideal location for an IOL placement is within the capsular bag.17 
The posterior chamber is bounded by 
1. The ciliary processes and the clefts between them 
2.
 The lens, resting in its capsular bag and the lens suspensory ligament and 
3.
 The pigment epithelium of the iris.18 
Advantages of PCIOL is reduced risk of complications associated with 
ACIOL  like bullous keratopathy, damage to anterior chamber angle structures, 
pupillary block glaucoma and pseudophakodonesis. It stabilises the ocular 
contents and decreases complications like iritis, CME and retinal detachment.18  
Positioning the lens closer to the nodal point and centre of rotation of the eye is 
associated with superior optical properties.19 
However, placement of a secondary IOL within the capsular bag is 
technically difficult because of the anterior and posterior capsular fusion 
secondary to fibrosis.17 
Secondarily implanted PCIOLs may be left unsutured in eyes that have intact 
capsular support.15 
 
Surgical Technique 
A 7 mm limbal incision is made. Anterior vitrectomy done and a 
viscoelastic material is injected into the capsular bag such that bag becomes 
 well inflated. The sterile lens is placed in the bag by passing the leading loop of 
the haptic into the inferior capsular fornix. The trailing loop is left protruding 
from the wound. The loop is flexed until convexity can be passed under the 
superior edge of anterior capsule in the edge. The lens is then dialled into the 
capsular bag. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CILIARY SULCUS FIXATION INTRAOCULAR LENS 
The ciliary sulcus is a slightly avascular area situated below posterior 
surface of iris and anterior capsule of lens32, 33. An IOL placement in this area is 
only slightly stable because of the surrounding structures and the anatomic 
variations.25, 32 Ciliary sulcus fixation of secondary PCIOL implantation 
requires at least peripheral capsular support and intact zonular support.34 
Study by Duffey et al, showed that the most likely location of ciliary 
sulcus is 0.94 mm behind the posterior surgical limbus in vertical meridian and 
0.5 mm in horizontal meridian. 
Bellucci et al, found that when the scleral fixation lens was sutured 1.5-
2.0 mm from limbus, 6 haptics were in ciliary sulcus, 6 in pars plana and 2 in 
the iris root. 
Advantages of ciliary sulcus fixation include easy surgery, safer in eyes 
with disorder associated zonular nucleus and when zonular dialysis or capsular 
rupture is seen intraoperatively.25 
Disadvantages  
Complications of ciliary sulcus fixation of IOL resulted from contact by 
the lens with posterior surface of iris and ciliary body. 
1. Decentration of the lens is due to postoperative inflammation and 
posterior synechiae. 
2. Pupil capture in which part or all of the optic displaces anterior to iris 
resulting in synechiae. 
 3. Posterior iris chafing syndrome due to anteriorly angulated IOL loops that 
rub against the posterior surface of iris. It is manifested with iris 
transillumination defects and transient microhyphemas with visual 
obscuration’s (transient ischemic amaurosis).35 
4. Erosion and perforations of the ciliary body resulting in haemorrhage or 
thrombosis. 
Surgical technique 
A 7 mm limbal incision is made and viscoelastic material is injected 
between the iris and capsule, synechiae between the posterior surface of the iris 
and the capsule is released with microscirrors or a blunt spatula. The lens is 
inserted between the iris and the capsular remnants. Lens centration and 
stability of IOL assessed. Viscoelastic from the anterior chamber is removed 
and wound closed. 
 
                                
 TRANSSCLERAL SUTURE FIXATED PCIOL 
The development of novel technique for fixating an IOL in the aphakic 
eye was introduced in 1980s. 
Suturing an IOL to sclera was first described by Girard in 1981 and 
modified later by Malbran and colleagues in 1986.36 
The ciliary sulcus placement of haptic is considered best for transscleral 
fixation of PCIOL because of its stable fixation avoiding major arterial circles 
of the iris, ciliary processes and trabecular meshwork. 37 
Malbran’s original technique first described two point scleral fixation. 
Subsequently, one- , three- and four point fixation was described.38 
Transscleral sutures can be placed vertically, obliquely or horizontally 
except at 3 and 9 o’clock position because of danger of injuring long ciliary 
arteries and nerves.39 
Advantages 
1. Includes advantages of non-sutured PCIOLs 
2. Used with limbal wound or penetrating keratoplasty 
3. Not dependent on presence of iris tissue 
4. Limited pseudophacodonesis 
5. Minimises uveal contact 
6. Vitreous supported by lens 
Disadvantages 
1. Technically difficult to insert 
 2. Increased operating time 
3. Extensive vitrectomy often required 
4. High chance of suture related problem 
5. Epithelial down growth from suture path 
6. Risk of retinal detachment 
7. Risk of suture passage through ciliary body 
8. Ciliary body erosion 
9. Long term dependence on fixation of the lens by a suture  
 
 
Surgical technique 
With respect to the technique, there are several variations in the procedure: 
1. The method of introducing suturing needles- ab externo or ab interno 
2. The method of securing the haptic with the fixating suture 
3. The number of points of PCIOL fixation 
4. The method of avoiding suture or knot erosion 
Scleral sutured lenses can be sutured from outside in (ab externo) or by 
passing the needle from inside out (ab interno). 
AB EXTERNO TWO POINT FIXATION TECHNIQUE 
In 1991, Lewis published ab externo sulcus fixation of PCIOL.40 
 Ab externo technique avoids the passage of the needle from inside out 
thereby decreasing the risk of haemorrhage, retinal detachment and lens 
malpositions. 
Disadvantages of Lewis method is less stable IOL fixation because of one 
point fixation of suture to sclera compared with two point fixation. 
The steps involved in the procedure are: 
1. Superior conjunctival peritomy is created from 4 o’ clock to 10 o’ clock 
position 
2. Partial thickness triangular sclera flap of 3×2 mm is created at 4 and 10 o’ 
clock positions 
3. A 7 mm corneal scleral wound is made and complete anterior vitrectomy 
performed 
4. Anterior chamber and retropupillary space is filled with viscoelastic 
5. A straight needle with 10-0 polypropylene suture is passed through 10 o’ 
clock sclera bed, 0.8 to 1 mm posterior to posterior surgical limbus 
parallel to iris 
6. Needle is passed behind the iris till it is visualised behind the pupil 
7. A 28 gauge needle is inserted through 4 o’ clock sclera bed 
8. Straight needle is inserted into the barrel of 28 gauge needle and syringe 
is withdrawn from the eye 
9. Loop of suture is withdrawn through the corneal scleral wound using a 
hook 
 10. Loop of suture is cut and each end is tied to the haptic of the IOL 
11. IOL is placed in the sulcus and rotated into its position 
12. A second 10-0 prolene suture is used to take a bite just anterior to the 
original suture exit point in the scleral bed. The long end of the second 
prolene suture is tied to both its short end and the lens-fixing suture 
13. This is repeated at the other end 
14. The sclera flap and conjunctival peritomy is closed 41 
 
 
 
 
 
 
 
 
 Variations  
Direct ab externo insertion of sutures
In this method, separate sutures are passed on two straight needles into 
the eye, one each through the scleral beds at 4 and 10 o’clock. The needles are 
passed directly through the superior corneoscleral wound and tied to the IOL. 
Basti et al modified this method, instead of passing direct needle; he used 26 
gauge hollow needles through which free end of polypropylene suture is passed. 
The hollow needle is passed ab externo through sclera and ciliary sulcus. The 
suture was withdrawn from the main incisio
advantage of this method is, it requires routinely available materials.
 
  
 
n with McPherson forceps. Main 
43
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 Small incision technique 44, 45 
This method used a small incision and a foldable PCIOL 
1. Two 5 mm peritomy and two 3×3 mm triangular half thickness sclera 
flaps are made 180º apart 
2. A 25 gauge needle is passed through one scleral bed to other 
3. Cut end of the suture is threaded through the full length of the needle and 
withdrawn 
4. A 3.5 mm self sealing incision is made through superior scleral bed 
5. Through kuglen hook prolene suture is retrieved out and cut and sutured 
to the haptics 
6. The IOL is folded and then inserted through superior incision 
7. Rest of the steps are same as above 
Regillo and Tidwell and Tsai and Tseng also described small incision 
techniques by modifying Lewi’s original method. 
Advantages46 
1.  No large corneal/scleral incision  
2.  No external corneal or scleral sutures, practically making sutureless 
surgery 
3. Early visual rehabilitation 
4. Intraoperative hypotony and globe collapse can be avoided with anterior 
chamber maintainer 
5.  Four point scleral fixation make IOL stable and avoid IOL tilt 
 6.  All IOL sutures are below scleral flap avoiding suture erosion and knot 
related inflammation 
7. Not much conjunctival handling so healthy
future trabeculectomy or even avoid bleb 
8. Greatly reduces surgical time with a resultant
inflammatory response.
 
 
 conjunctiva can be spared for 
 
 reduction in postoperative 
 
        
 
 
  
Haptic looping method47 
1. A superior corneoscleral wound is created. 
created at 2 and 8 o’ clock positions
2. 1mm posterior to the limbus, a straight needle is passed into the globe to 
make a port and withdrawn. It is again inserted in the reverse position 
with attached 10-0 prolene suture
3. Suture is pulled out through the corneoscleral wound using a lens dialer
4. This is repeated at the opposite scleral bed
5. Suture loop is passed through the haptic eyelet. At one end, suture loop is 
passed over the IOL and at the other end loop is passed over the ha
lock the suture over the eyelet
6. The IOL is implanted  in the posterior chamber
7. Needle is passed through scleral bed and suture is tied and cut long.
 
 
Peritomies and sclera flaps are 
 
 
 
 
 
 
ptic to 
 
 
  
Ab Externo Continuous-loop Fixation
This method allows burying of the knot and does not require a scleral 
flap, but it can cause torque and tilt.
1. A peritomy is made from 4
wound is created 
2. A straight needle with 10
to other, 1 mm from the limbus
3. The needle is turned around and passed back into the sclera bed emerging 
through the original scleral bed
4. Both sutures are withdrawn and cut
5. One cut end at each side is passed through the corresponding eyelets and 
the sutures are tied to themselves
6. The lens is placed in the sulcus and long loops are cut, shortened and tied 
7. The final knot is then rotated into the eye
38 
 
-10 o’ clock and a superior corneoscleral 
-0 prolene suture is passed from one 
 
 
 
 
 
sclera bed 
 
 
  
Ab Externo Continuous-loop Fixation with Scleral Flaps
1. Conjunctival peritomies are created at 3
2. 7 mm clear corneal incision is made superiorly
3. At 3 and 9 o’ clock positions, L shaped sclera incisions are made with 
limbal based flaps 
4. A 10-0 prolene suture with needle is passed through the sclera bed and 
retrieved through the s
5. This suture is threaded to an eyelet of the haptic, and the suture is passed 
back into the eye through superior corneal incision and through another 
27 G needle is guided out through the same sclera bed.
6. Same procedure repeated on the other side
7. IOL is inserted through the superior corneal wound  into posterior 
chamber 
8. Sutures are pulled, tightened and sutured. The knot is rotated into the eye
9. Conjunctival and sclera flaps are closed
48 
 and 9 o’ clock position
 
uperior corneal incision with 27 G needle
 
 
 
 
 
 
 
 KNOTLESS TECHNIQUE49, 50 
1. A 6-7 mm scleral tunnel incision made at 12 o’clock position 
2. A double armed 10-0 polypropylene suture with straight needle was used 
3. One straight needle was passed 1.5 mm behind the limbus at 3 o’clock 
position through full thickness sclera and retrieved through opposite side 
by 26 G needle 
4. The stretched suture is pulled out through sclerocorneal tunnel 
5. The suture is cut and suture ends are passed through the eyelets of the 
IOL and tied 
6. The IOL is inserted into the sulcus and sutures pulled 
7. The corneoscleral wound is sutured 
8. The needle of the 10-0 prolene  suture is passed in ‘Z’ shape with at least 
5 indentations to secure the IOL 
9. Suture is cut without making any knot and covered with conjunctiva  
 
 
 
 AB INTERNO TWO POINT FIXATION51 
In 1990, Smiddy and colleagues described the technique for implanting 
scleral fixated posterior chamber IOLs which produced good visual results with 
a low rate of complications and which was technically straight forward. 
The main disadvantage of this method is the risk of haemorrhage 
associated with passage of needle from inside out through sclera from 3 to 9 
o’ clock positions. 
The basic steps of an ab interno sclera fixation are 
1. A double armed polypropylene suture is cut and the ends are tied to the 
haptics of  the IOL with square knots 
2. A 8 mm superior peritomy is done with a fornix based conjunctival flap, 
with a separate radial incisions at 3 and 9 o’ clock positions 
3. Anterior chamber is entered with a paracentesis  knife and anterior 
vitrectomy performed 
4. IOL attached with the sutures are placed in the superior incision site and 
needle is passed through the incision, pupil, behind the iris and out 
through the sclera 1mm posterior to the surgical limbus at 3 o’ clock 
5. The other IOL attached needle is passed through in a similar fashion at 9 
o’ clock position 
6. The suture ends are left long and are laid flat under the conjunctiva and 
sutured with 8-0 chromic catgut 
7. Limbal incision is then closed. 
  
 
 
AB INTERNO FOUR POINT FIXATION WITH HAPTIC LOOPING
This method introduced the use iris hooks to facilitate ciliary sulcus 
visualisation and also provides a quick way for four point fixation of sutures. 
The steps of the procedure are
1. Limbal based triangular scleral
2. Flexible iris retractors are placed at 2,4,8 and 10 o’ clock positions
3. A long 27 G bent needle is passed ab externo at 3 o’clock position near 
limbus. It is pushed till it exits at 9:15 o’clock position ab intern
                    
 
 
 flaps are made at 3 and 9 o’clock position
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o fashion. 
 4. A straight long needle with 10
the hollow needle. The hollow needle is withdrawn into the vitreous 
cavity and then slightly turned to direct it towards 8:45 o’clock position 
and is passed out of the eye 
5. The straight needle with the suture is withdrawn from the 27 G hollow 
needle and then out of the eye
6. A limbal incision is made at 12 o’clock and anterior chamber entered 
with a blade 
7. The intraocular loop is withdrawn from the eye with a hook 
8. The above steps of the procedure are repeated from the opposite side
9. Each loop is passed through the eyelets of the haptic and then looped over 
haptic end 
10. The PCIOL is inserted, the sutures tied and the scleral flaps sutured 
closed  
 
 
 
 
 
 
-0 prolene with blunt end is advanced into 
 
 
 
 
 
 
 PARS PLANA FIXATION51 
In 1981, Girard described the technique of pars plana fixation which 
never became popular.  
The pars plana is relatively avascular and lies anterior to the retina, thus 
avoiding the complications of haemorrhage and retinal detachment. Other 
advantages include avoiding the contact of IOL to iris and pars plicata. Pigment 
dispersion can also be avoided. 
For a pars plana fixation, few modifications in the standard posterior 
chamber IOL has to be done 
1. The diameter of the lens is increased  to about 17 mm and diameter of 
biconvex optic to 7 mm 
2. The haptics are 10 or 20 degrees angled backwards 
3. PMMA is the material of choice  
4. IOL would preferably have eyelets to facilitate suture fixation. It is best 
to use three point fixation with one haptic having two eyelets for a stable 
fixation 
The basic steps for Teichmann’s pars plana fixation include: 
1. Suture is tied around each of the three eyelets of the lens. 
2. IOL is then inserted through the superior limbal incision and IOL is 
oriented either vertically or obliquely 
3. The pars plana fixation proceeds from inside out. The ora serrata is 
situated 5 to 6 mm posterior to the limbus and ciliary body. To enter the 
 pars plana safely, sclera is entered 3 to 5 mm behind the limbus with the 
needle being parallel to the iris plane.
4. Two point fixation of the sutures or double transscleral pars plana 
fixation is used for increased stability of the IOL.
 
 
 
COMPLICATIONS  
Complications associated with scleral fixation PCIOL is suture erosion, 
glaucoma, cystoids macular oedema
tilt or redislocation and vitreous hemorrhage.
Suture erosion 
In Solomon’s series, suture exposure was the most common complication 
occurring in 73% of cases.54
Suture erosion creates a communication between intra and extraocular 
environment with resultant microbial contamination.
 
 
 
, retinal detachment, endophthalmitis, lens 
52, 53 
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 Erosion, breaking or wearing of the 10-0 polypropylene occurs due to the 
lack of fibrous reactions around the IOL haptic.55 The incidence of suture 
erosion ranged from 5% to 50% when sutures were covered with conjunctiva 
alone. When sutures were covered with sclera flap, incidence was reduced to 
11% to 17.9%. Incidence was dropped to 0 to 6.7% when the suture knot was 
rotated into the sclera.54 
 Suture erosion can be treated by either cutting the free ends flush on the 
knot, cauterising the knot, using a sclera patch graft or by revising the scleral 
flap.54 
IOL tilt/ decentration 
Lack of lens capsule support can potentially result in IOL tilt and to 
decentration. This is associated with oblique astigmatism and myopic shift and 
lateral shift of focus.38 
Small degrees of lens tilt (less than 10º) and decentration (less than 2 
mm) are asymptomatic and clinically insignificant.54 
The incidence of IOL tilt or decentration has been reported to be 5- 10 % 
in literature. In Mazhri ZU and Qadri WM study incidence of IOL tilt was 8% 
and only in one patient it was clinically significant. Delayed subluxation 
occurred in one patient after one and half years postoperatively.56  
In a study by Ghaseminejed AK and Ahmadieh H, sclera fixated IOL 
position was good in 72.2% and mild IOL tilt was seen in 16.7%. Due to 
breakage of one of the sutures, IOL sunset was seen in one eye after 2.5 years.57 
 IOL tilt occurs due to the torque created by the asymmetric suture 
placement on the lens.54 
A decentered PCIOL may result from a number of factors. These include 
asymmetric attachment of haptic sutures; failure of placing the needle 180º apart 
through the sclera; and suture loosening, breakage, or slippage on the haptics.54 
Lens malposition can be prevented by use of an IOL with eyelets on the 
haptics, symmetrically securing the suture to the eyelet and passing the needle 
equal distance from the limbus and exactly180º apart.54 
Hyphema/ vitreous haemorrhage 
Suturing PCIOLs required passage of needle through the vascular uveal 
tissue with an associated risk of bleeding.38 In most of the cases this was minor 
and usually resolved spontaneously. 
Vitreous haemorrhage (16%) and hyphema (10%) was the most common 
complication in Mazhri ZU and Qadri WM study. This was slightly higher 
compared to other studies. After modification of the technique by Basti et al, 
incidence was decreased from 20% to 13.3 %.56 
Hidemann and Dunn reported 11% incidence of vitreous haemorrhage 
and hyphema. Holland and colleagues in their 115 cases reported no vitreous 
hemorrhage.56 
A transscleral penetrating point located 2 mm posterior to surgical limbus 
carried a higher risk for bleeding because the major arterial circle of iris is 
 situated mainly in the ciliary body, which is approximately 2 mm from the 
surgical limbus.37 
Placing the suture anterior i.e. 0.5 -1 mm behind the surgical limbus and 
preventing 3 and 9 o’ clock positions may reduce bleeding risk by avoiding the 
long posterior ciliary arteries and vascular ciliary body. Using the minimum 
number of sutures and inserting the needle perpendicular to the sclera in ab 
externo technique also decreased the incidence of bleeding.38 
Endophthalmitis 
Endophthalmitis is a dreaded complication, which can occur after any 
intraocular procedure.38 The incidence of endophthalmitis following cataract 
surgery has been reported to be 0.08% to 0.26%.58  
Although pathogens can be introduced into the eye at the time of surgery, 
they can also gain entry through exposed sutures as in suture-fixated 
PCIOLs.38,60 
Increased surgical complexity and complications such as posterior 
capsule rupture and associated vitreous loss increase the risk of 
endophthalmitis.59 
Hatch et al. reported a nearly 10 fold increase in risk of endophthalmitis 
when an unplanned anterior vitrectomy is performed.59 
Endophthalmitis following sutured PCIOLs occurred primarily due to 
exposed suture ends, and can be prevented by leaving the suture ends long, 
 tying the knot in the depths of a partial thickness scleral incision or by rotating 
knots into the sclera.38, 53 
Glaucoma 
Postoperative glaucoma incidence following TS PCIOL varies from 4.9 
to 40%. Study by Nottage et al found the incidence of postoperative glaucoma 
was 4% which was slightly lower than the reported range.60 
In McAllister AS and Hirst LW study the incidence of post operative 
ocular hypertension was 30.5%. Among this 44% had a history of glaucoma.53 
Risk factors for post operative ocular hypertension include a previous 
history of glaucoma, trauma, treatment of retinal detachment with silicone oil, 
viscoelastic use, corticosteroid use and hyphaema53 
Mazhri ZU and Kadri WM study observed glaucoma to be the most 
common complication following secondary SFIOL, 8 eyes(16%) followed by 
vitreous haemorrhage in 4 eyes(8%) and hyphema in 2 eyes(4%). Clinically 
significant IOL tilt occurred in 1 case (2%).52 
Glaucoma was seen in 3 cases post operatively of which 2 cases required 
treatment.61 
CME or Uveitis 
The risk of uveitis or cystoids macular oedema associated with sclera 
fixated PCIOL is less than that seen in ACIOL or iris fixated IOLs. Incidence of 
CME after TSPCIOL ranges from 1.5% to 22.6%.60 
 In Ma DJ et al study, which compared ciliary sulcus and pars plana 
locations for PCIOLs, CME was seen in 29% of ciliary sulcus PCIOL group and 
6.8% in pars plana  PCIOL group and the total incidence in both the groups 
were 5.1%.37 
Many factors contribute to the occurrence of CME after sclera fixation of 
PCIOLs. Most of the cases were associated with vitreous loss either at the initial 
event with loss of capsular support or during sclera fixation. Other contributing 
factor for development of CME is light induced retinal injury. This is due to the 
increased operating time in sclera fixation of PCIOL.38 
The main stay of treatment of CME is with topical NSAIDs and topical 
steroids. Topical ketorolac has also been shown to reduce angiographic CME in 
a randomised controlled study. For refractory cases, peribulbar injection of 
steroid, systemic steroids and oral acetozolamide have been used.38 
Retinal Detachment 
Following TSPCIOL insertion, post operative retinal detachment occurs 
at an incidence of 3.1% to 9.5%. In Nottage JM et al study, post operative 
retinal detachment occurred in 2 cases (1.9%).60 
Retinal detachment is more common when anterior vitreous face is 
disturbed with or without vitreous prolapsed.38 
In young patients, there is a greater risk of retinal detachment with SF 
PCIOLs due to the ocular pathology and posterior hyaloids. The risk of retinal 
detachment from ectopia lentis and axial myopia ranges from 9% to 19%.53 
 The risk of retinal detachment increases with too posterior placement of suture 
fixation.56 
In Ghaeseminejad AK study, incidence of retinal detachment is 3.2%.57 
Scleral PCIOL fixation often requires complete vitrectomy; otherwise 
vitreous strands can adhere to the IOL haptic leading to vitreoretinal traction 
and to retinal detachment.57 
Lyle and Jin reported that the rate of RD was higher in the PCIOL group 
than the ACIOL group. Posterior vitreous detachment and vitreous liquation 
occur within one year post operatively in most aphakic eyes. This explains 
decreased RD rate when secondary IOL is implantation is performed after one 
year.54 
 
 
 
 
 
 
 
 
 
 
 
 AIM OF THE STUDY 
The aim of the study is to analyse  
1. The visual outcome in secondary posterior chamber intraocular lens 
implantation 
2. The complications associated with secondary posterior chamber 
intraocular lens implantation 
 
  
 MATERIALS AND METHODS 
This prospective clinical study was conducted in department of 
ophthalmology, Coimbatore medical college from September 2011 to 
September 2012. 
MATERIALS 
The study included 30 aphakia patients who presented to our outpatient 
department. These patients were treated with different secondary posterior 
chamber intraocular lens implantation depending on the presence or absence of 
capsular remnants. These patients were followed up for a period of 6 weeks 
postoperatively. 
A standard case Proforma was maintained and detailed clinical history 
was taken. These included,  name of the patient, age, sex, address, duration of 
aphakia, history of trauma, history of previous surgery and its details, history of 
systemic diseases like diabetes mellitus, systemic hypertension, cardiac disease, 
bronchial asthma, epilepsy was noted. Routine investigations like blood 
pressure measurement, random blood sugar and urine sugar testing was done. 
These patients were taken up for surgery after control of systemic diseases.  
METHODS 
Preoperative uncorrected and best corrected visual acuity was noted using 
Snellen’s distance visual acuity chart. 
Anterior segment examination done with slit lamp and findings noted. 
Presence of aphakia and status of capsular remnants was noted. Integrity of the 
 posterior capsule was noted. Integrity of the posterior capsule whether intact, 
partially present or total absence of capsular remnants was noted after full 
dilatation of the pupil. Based on the capsular status, type of secondary PCIOL 
implantation was decided. Presence of any vitreous strands in pupillary area, 
anterior chamber or vitreous incarceration in scleral wound was noted. Pupillary 
abnormalities, posterior synechiae and presence of peripheral iridectomy and its 
position noted. 
INTRAOCULAR PRESSURE 
Goldmann’s applanation tonometer was used to measure IOP in all 
patients preoperatively. 
FUNDUS EXAMINATION 
Fundus was examined with direct ophthalmoscope and indirect 
ophthalmoscope using +20 D lens to assess the peripheral retina. Fundus was 
also examined with slit lamp using +90 D lens. 
IOL POWER CALCULATION 
Keratometry was done with Bausch and Lomb keratometer. K1 and K2 
readings were taken. Axial length of the eye was done with the help of ‘A’ scan. 
IOL power was calculated with SRK II formula using 118.2 as A constant. 
INCLUSION CRITERIA 
1. Patients with unilateral aphakia 
2. BCVA better than or equal to 6/60 by Snellen’s visual acuity chart 
3. Normal fundus as seen by direct and indirect ophthalmoscope 
 EXCLUSION CRITERIA 
1. Patients with central corneal opacity, glaucoma, uveitis 
2. Any fundus abnormality affecting visual function like macular 
degeneration, chorioretinal atrophy etc., 
3. BCVA worse than 6/60 by Snellen’s visual acuity chart 
4. Patients of bilateral aphakia 
5. One eyed patients 
PRE-OPERATIVE PREPARATION 
After taking detailed medical history and thorough check up of blood 
pressure, blood sugar, cardiovascular system, respiratory system, gastro 
intestinal and central nervous assessment and eye lashes were cut. 
MYDRIASIS 
Preoperatively pupils were dilated using 0.5% tropicamide, 10% 
phenylepherine and flurbiprofen. These drops were instilled every 15 minutes 
one hour before surgery. 
Preoperatively antibiotic eye drops were instilled one hour before 
surgery. 
 
AKINESIA AND ANAESTHESIA 
Akinesia and anaesthesia of the eye was achieved by peribulbar injection 
of 3 ml of 2% xylocaine with 5 IU/ml of hyaluronidase and 1:200000 adrenaline 
with 2ml of bupivacaine. This was given with 23G needle. 
 Peribulbar block was given at the junction of outer one third and inner 
two thirds of the lower orbital rim. The needle was directed away from the eye 
and towards the floor of the orbit with eye in primary gaze. In the superior 
orbital margin injection was given at the junction of medial one- third and 
lateral two third towards the roof of the orbit. When orbicularis oculi function 
remains active seventh cranial nerve akinesia was achieved by O’Brien akinesia 
technique with 2ml of 2%lidocaine with 1:200000 adrenaline with 
hyaluronidase. The condyloid process of the mandible was palpated just in front 
of tragus of ear by asking the patient to open and close his or her mouth. 
Anaesthetic mixture was injected over the center of condyloid process at a depth 
of 1cm with 23G needle. 
LOWERING OF IOP: 
 The IOP was reduced by giving tab. Acetazolamide 250mg one hour 
before the surgery. Ocular hypotony was also achieved by ocular compression 
after peribulbar block using steady digital pressure on globe for 20 seconds 
periods separated by 10 seconds interval. 
CLEANING OF SKIN AND CONJUNCTIVA: 
Preparation included use of 5% povidone iodine to clean the surrounding 
skin. Skin area that extended from midline to beyond lateral canthus and from 
above the eyebrows to well down onto the cheek was cleaned. 5% iodine 
solution was applied into conjunctival cul de sac with subsequent saline wash to 
cleanse the conjunctiva. 
 DRAPING THE SURGICAL FIELD: 
The eye and surrounding sterile periocular region was draped with a 
sterile cloth with a 3cm×3cm round opening for the eye. 
SURGICAL TECHNIQUE: 
Depending on the capsular remnants status technique of PCIOL was 
decided. 
SECONDARY PCIOL IMPLANTATION: 
• Step 1: Superior rectus bridle suture and conjunctival peritomy 
o Superior rectus bridle suture was applied and a conjunctival 
peritomy was done for 7mm at superior limbus. 
• Step 2: Hemostasis 
o Bipolar wet field cautery was used for hemostasis 
• Step 3: Scleral flap 
o Superior scleral flap of 6.5mm length was made of 2/3rd thickness 
1mm posterior to the limbus. 
• Step 4: AC entry 
o AC was entered with a 2.8mm diameter keratome. The keratome 
entry was extended up to the width of the external sclera flap of 
6.5mm. 
• Step 5: Automated 23G Anterior Vitrectomy 
o A thorough Automated 23 G Anterior vitrectomy was done. Any 
peripheral cortical remnants were cleared with the vitrectomy. 
 • Step 6: Viscoelastic injection 
o The viscoelastic was injected to inflate the capsular bag and for 
maintaining anterior chamber. 
• Step 7: Synechiolysis 
o Any synechiae between the posterior iris and capsule was released 
using blunt spatula. Anterior and posterior capsule were separated. 
• Step 8: IOL implantation 
o Rigid PMMA lens was implanted into the capsular bag and dialled 
for centration. 
• Step 9: Removal of viscoelastic 
o Viscoelastic substance was removed using Simcoe’s irrigation 
aspiration cannula. 
• Step 10: Wound closure 
o Anterior chamber was reformed and wound closed. 
• Step 11: Conjunctival approximation and subconjunctival injection 
o Conjunctival approximation was done and 1 ml of subconjunctival 
injection containing 0.5ml gentamicin and 0.5ml dexamethasone 
was given. 
Pad and bandage was applied. 
 
 
 SECONDARY CILIARY SULCUS FIXATION OF IOL 
The procedure from step 1 to 5 was same and included superior rectus 
bridle suture, conjunctival peritomy, hemostasis, scleral flap, AC entry and 
automated 23 G anterior vitrectomy. 
• Step 6: viscoelastic injection 
o Viscoelastic was injected between posterior iris and capsule. It was 
also used to maintain the anterior chamber. 
• Step 7: Synechiolysis 
o Any synechiae between the posterior surface of the iris and 
capsular remnants was released with blunt spatula or cut with 
Vanna’s scissors. 
• Step 8: IOL implantation 
o A rigid PMMA IOL was implanted in the ciliary sulcus between 
posterior surface of the iris and the capsule. 
• Step 9 to 11: Removal of viscoelastic, wound closure conjunctival 
approximation and subconjunctival injection was given as described in 
above procedure. 
SECONDARY SCLERAL FIXATED IOL IMPLANTATION 
• Step 1 and 2: superior rectus bridle suture, conjunctival peritomy and 
hemostasis was achieved as described above. 
• Step 3: Scleral flap 
 o Superior sclera flap of 6.5 mm length was made of 2/3rd thickness 1 
mm from the limbus. Two 2mm 2/3rd thickness sclera flaps are 
made 2mm from the limbus at 2 o’clock and 8 o’clock 
respectively. 
• Step 4: AC entry 
o AC was entered with a 2.8mm diameter keratome. The keratome 
entry was extended up to the width of the external sclera flap of 
6.5mm. 
• Step 5: Automated 23G Anterior Vitrectomy 
o A thorough Automated 23 G Anterior vitrectomy was done. Any 
peripheral cortical remnants were cleared with the vitrectomy. 
• Step 6: suture passage 
o A 10-0 polypropylene suture end was threaded into the bore of 26G 
needle and passed into the scleral flap at 2 o’clock position. The 
needle is passed posterior to the iris into the posterior chamber. 
The suture is taken out through the main scleral wound by 
McPherson forceps. The same procedure was repeated at 8 o’clock 
position. 
• Step 7:  Suture tying to the haptics 
o The two suture ends were tied to the haptics of rigid PMMA lens. 
Care was taken to ensure that the 2 o’clock suture is matched with 
superior eyelet of the haptic and the inferior haptic eyelet likewise 
 related to 8 o’clock suture exiting the inferior aspect of the groove. 
The knots were tied to the haptic in 3:2:1 pattern. 
• Step 8: IOL insertion 
o IOL with sutures tied to the haptics was inserted into the anterior 
chamber and placed in the ciliary sulcus and centered. The suture 
was gently pulled and scleral flaps were sutured and the knot 
buried in the scleral bed in the groove. 
• Step 9: Wound closure 
o The main superior scleral flap was sutured with 10-0 nylon suture 
and anterior chamber reformed with air. 
• Step 10: Conjunctival approximation and subconjunctival injection 
o Conjunctival approximation was done and 1 ml of subconjunctival 
injection containing 0.5ml gentamicin and 0.5ml dexamethasone is 
given. 
Pad and bandage was applied. 
POSTOPERATIVE MANAGEMENT 
Postoperatively patients were treated with topical antibiotic-steroid drops 
for a period of 6 weeks which was gradually tapered. 
Patients were followed up for a period of 6 weeks. 
Postoperative day 1: 
 Patient was examined for 
1. Wound approximation 
 2. Corneal status 
3. Anterior chamber depth and reaction 
4. IOL centration 
5. BCVA with Snellen’s distance visual acuity chart 
6. IOP by applanation tonometry. 
Postoperative 1 week/ 6 week 
Patient was examined for 
1. BCVA with Snellen’s distance visual acuity chart 
2. Corneal status 
3. Anterior chamber depth and reaction 
4. IOL centration 
5. IOP by applanation tonometer 
6. Fundus evaluation by direct ophthalmoscope, indirect 
ophthalmoscope and with +90 D lens using slit lamp.  
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 RESULTS AND OBSERVATION
A total of 30 aphakia
lens implantation. 
Table 1: Age distribution 
In our study 50% of the patients belonged to the age group of 61
years. 3.3% of the patients were in the age group of 41
were above 80 years. 
AGE GROUP 
41-50 
51-60 
61-70 
71-80 
81-90 
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 TABLE 2: SEX DISTRIBUTION
GENDER 
MALE 
FEMALE 
 
In our study, majority of the patients 
males were 37%. 
 
 
 
 
 
63%
 
NO. OF CASES PERCENTAGE
11 36.7 
19 63.3 
were females accounting for 63% and 
37%
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 TABLE 3: LATERALITY
 
LATERALITY 
RIGHT EYE 
LEFT EYE 
 
 53% cases presented with right eye aphakia and 47% cases with left eye 
aphakia. 
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 TABLE 4: STATUS OF THE OTHER 
 
OTHER EYE 
CATARACT 
PSEUDOPHAKIA 
 
 
 
In 53% cases, other eye had pseudophakia and in 47% cataractous lens.
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 TABLE 5: PRE-OPERATIVE BCVA
VISUAL ACUITY 
6/6 
6/9 
6/12 
6/18 
6/24 
6/36 
6/60 and less 
 
In our study, 17 cases (56.6%) had of BCVA 6/18 and above. 30% patients had 
6/24 BCVA. 4 cases (13.3%) had BCVA of 6/36 and less.
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 TABLE 6: STATUS OF POSTERIOR CAPSULE 
 CAPSULAR REMNANTS
INTACT POSTERIOR 
CAPSULE 
PARTIALLY PRESENT
ABSENT 
 
 
17 cases (56.3%) in our study did not have capsular remnants suggestive either 
previous surgery of ICCE or large posterior capsular rupture. 10 cases (33.3%) 
had partial capsular remnants and 3 cases (10%) were seen with intact posterior 
capsule. 
ABSENT
CAPSULAR REMNANTS
 
 NO. OF CASES PERCENTAGE
3 10
 10 33.3
17 56.6
INTACT POSTERIOR 
CAPSULE
PARTIALLY 
PRESENT
 
 
 
 
 
 TABLE 7: PROCEDURE 
PROCEDURE 
 IN THE BAG PCIOL 
 CILIARY SULCUS IOL
SFIOL 
 
17 cases (56.6%) underwent SFIOL who had total absence of capsular 
remnants. 10 cases (33.3%) had partial capsular remnants and underwent ciliary 
sulcus fixation IOL. 3 cases (10%) had intact posterior capsule and in the bag 
PCIOL was done.  
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 TABLE 8: POSTOPERATIVE BCVA ON DAY 1
BCVA 
6/6 
6/9 
6/12 
6/18 
6/24 
6/36 
6/60 and less 
 
In our study, on the 1st postoperative day 18 cases (60%) had BCVA of 6/18 and 
above. 3 cases (10%) had BCVA of 6/24. 9 cases (30%) had BCVA of 6/36 and 
above. 
0
1
2
3
4
5
6
7
8
6/6 6/9
 
NO. OF CASES PERCENTAGE
0 0 
2 6.7
8 26.7
8 26.7
3 10
4 13.3
5 16.6
6/12 6/18 6/24 6/36 6/60 and 
lessvisual acuity
 
 
 
 
 
 
 
 
 TABLE 9: COMPLICATION PROFILE ON 1
COMPLICATION 
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On the 1st operative day, strait keratopathy was seen in 4 cases (13.3%), corneal 
oedema in 5 cases (16.6%) and anterior uveitis was seen in 4 cases (13.3%).  
1 case (3.3%) developed hyphema and same patient had increased IOP. IOL 
decentration was seen in 1 case (3.3%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 10: BCVA 1 WEEK POSTOPERATIVELY
BCVA 
6/6 
6/9 
6/12 
6/18 
6/24 
6/36 
6/60 and less 
 
After 1 week postoperatively, 25 cases (83.3%) had BCVA of 6/18 and above. 2 
cases (6.6%) had BCVA of 6/24. 3 cases (10%) had 6/36 of BCVA.
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 TABLE11: COMPLICATION PROFILE 1 WEEK POSTOPERATIVELY
COMPLICATION 
SK 
CORNEAL EDEMA 
HYPHAEMA 
AC SHALLOW 
ANTERIOR UVEITIS 
PUPILLARY CAPTURE
IOL DECENTRATION 
INCREASED IOP 
VITREOUS HEMORRHAGE
 
0
0.5
1
1.5
2
2.5
3
3.5
4
SK CE HY
NO. OF CASES PERCENTAGE
1 3.3
2 6.6
0 0 
0 0 
4 13.3
 0 0 
0 0 
1 3.3
 0 0 
AC SH AU PC ID GL VH
COMPLICATION
 
 
 
 
 
 
 
 After 1 week postoperatively, 4 cases (13.3%) had anterior uveitis even with 
treatment. Corneal oedema was seen in 2 cases (6.6%) and striate keratopathy in 
1 case (3.3%). Increased IOP was seen in 1 case (3.3%). 
  
 Table 12: BCVA 6 WEEK POSTOPERATIVE
VISUAL ACUITY 
6/6 
6/9 
6/12 
6/18 
6/24 
6/36 
6/60 and less 
 
After 6 weeks postoperatively, 25 cases (83.3%) achieved BCVA of 6/9 and 
above. 1 case (3.3%) had BCVA of 6/24, 3 cases 
only 1 patient had BCVA of less than 6/60 which was attributed to the 
development of retinal detachment.
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LY 
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4 13.3
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1 3.3
3 10
1 3.3
(10%) had BCVA of 6/36 and 
 
6/12 6/18 6/24 6/36 6/60 and 
less
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 TABLE13: COMPLICATION PROFILE 6 WEEK POSTOPERATIVELY
COMPLICATION 
CORNEAL EDEMA 
INCREASED IOP 
IOL DECENTRATION
SUTURE EROSION 
CYSTOID MACULAR EDEMA
RETINAL DETACHMENT
 
2 patients had cystoid macular 
vision in these patients who were treated appropriately.
retinal detachment at 6 weeks postoperatively and was treated for the same.
 
 
0
0.5
1
1.5
2
CE GL
NO. OF CASES PERCENTAGE
1 
0 
 0 
0 
 2 
 1 
oedema contributing to the defective 
1 patient developed 
ID SE CME RD
COMPLICATION
 
 
3 
0 
0 
0 
7 
3 
 
 
 TABLE 14: BCVA ON DAY 1 POSTOPERATIVELY
 
2 cases (66.6%) had BCVA of 6/18 and above in patients with in the bag 
PCIOL and 1 case (33.3%) had BCVA of 6/24.
6/6 6/9 6/12
BCVA IN THE BAG PCIOL
6/6 
6/9 
6/12 
6/18 
6/24 
6/36 
6/60 and less 
 
 
6/18 6/24 6/36 6/60 AND 
LESS
BCVA
 
CILIARY 
SULCUS IOL SFIOL
0 0 
0 2 
1 3 
1 2 
1 1 
0 0 
0 2 
 
PCIOL
CIL SULCUS
SFIOL
 
0 
0 
4 
5 
1 
4 
3 
 In ciliary sulcus fixation IOL, 7 cases (70%) had BCVA of 6/18 and above. 1 
case (10%) had BCVA of 6/14 and 2 cases (20%) had BCVA of 6/36. 
In SFIOL group, 9 cases (52.9%) achieved BCVA of 6/18 and above. 1 case 
(5.8%) had BCVA of 6/24 and 7 cases (41.1%) had BCVA of 6/36 and less on 
1st postoperative day.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 15: COMPLICATION PROFILE ON 1
DAY 
COMPLICATION 
WOUND LEAK 
SK 
CORNEAL EDEMA 
HYPHAEMA 
AC SHALLOW 
ANTERIOR UVEITIS 
PUPILLARY CAPTURE
IOL DECENTRATION 
INCREASED IOP 
VITREOUS HEMORRHAGE
 
There were no complications seen in PCIOL group on 1
day.  
0
0.5
1
1.5
2
2.5
3
3.5
4
WL SK CE HY
ST
 POSTOPERATIVE 
PCIOL CIL SULCUS IOL 
0 0 
0 2 
0 1 
0 0 
0 0 
0 2 
 0 0 
0 0 
0 0 
 0 0 
st
 postoperative 
AC 
SH
AU PC ID GL VH
PCIOL
CIL SUL IOL
SFIOL
SFIOL 
0 
2 
4 
1 
0 
2 
0 
1 
1 
0 
 
 In patients with ciliary sulcus fixated IOL, 2 cases (20%) had SK and 2 
cases (20%) had anterior uveitis and 1 case (10%) had corneal oedema. 
 In SFIOL group, 1 patient (5.8%) developed hyphema and increased 
IOP. 4 cases (23.5%) had corneal oedema on 1st postoperative day and 2 cases 
(11.8%) had anterior uveitis. IOL decentration was seen in 1 case (5.8%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 16: BCVA 1 WEEK POSTOPERATIVELY
In the PCIOL group, 2 cases (66.6%) achieved BCVA of 6/6 within 1 
week postoperatively and 1 case (33.3%) had BCVA of 6/9.
0
1
2
3
4
5
6
7
6/6 6/9 6/12
BCVA IN THE BAG PCIOL
6/6 2
6/9 1
6/12 0
6/18 0
6/24 0
6/36 0
6/60 and less 0
 
 
6/18 6/24 6/36 6/60 and 
less
 
CILIARY 
SULCUS IOL SFIOL
 7 5 
 0 7 
 1 2 
 0 0 
 1 1 
 1 2 
 2 0 
 
 
 
 
 
 
 
 
 
 
 
PCIOL
CIL SUL IOL
SFIOL
 
  In ciliary sulcus IOL implantation group, 8 cases (80%) achieved BCVA 
of 6/12 and above. 1 case (10%) had BCVA of 6/24 and 1 case (10%) had 6/36 
of BCVA.  
In SFIOL group, 14 cases (82.3%) achieved BCVA of 6/12 and above. 1 
case (5.8%) had BCVA of 6/24. 2 cases (11.7%) achieved BCVA of 6/36. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE17: COMPLICATION PROFILE 1 WEEK POSTOPERATIVELY 
COMPLICATION 
IN THE BAG 
PCIOL 
CILIARY 
SULCUS IOL 
SFIOL 
SK 0 1 0 
CORNEAL EDEMA 0 0 2 
HYPHAEMA 0 0 0 
AC SHALLOW 0 0 0 
ANTERIOR UVEITIS 0 2 2 
PUPILLARY CAPTURE 0 0 0 
IOL DECENTRATION 0 0 0 
INCREASED IOP 0 0 1 
VITREOUS HEMORRHAGE 0 0 0 
 
 
No complications were seen in the PCIOL group. 
0
0.5
1
1.5
2
2.5
SK CE HY AC SH AU PC ID GL VH
PCIOL
CIL SUL IOL
SFIOL
  In ciliary sulcus IOL implantation group, 2(20%) patients had anterior 
uveitis and 1(10%) patient had SK. 
In SFIOL group, 1(5.8%) patient had increased IOP, 2(12%) patients had 
corneal oedema and 2 cases (11.7%) of cases had persistent anterior uveitis in 
spite of treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 18: BCVA 6 WEEKS POSTOPERATIVELY
0
1
2
3
4
5
6
7
8
9
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6/6 6/9 6/12
BCVA IN THE BAG PCIOL
6/6 3
6/9 0
6/12 0
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6/24 0
6/36 0
6/60 and less 0
 
6/18 6/24 6/36 6/60 and 
less
PCIOL
CIL SUL IOL
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SULCUS IOL SFIOL
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 1 0 
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 In PCIOL group, all the patients (100%) achieved BCVA of 6/6 by 6 
weeks postoperatively.  
In ciliary sulcus IOL group, 8 cases (80%) achieved BCVA of 6/6, 1 
(10%) patient had 6/24. 1 case (10%) achieved BCVA of 6/36 and the cause for 
defective vision was due to the complication. 
In SFIOL group, 14 cases (82.3%) achieved BCVA of 6/9 and above. 2 
cases (11.7%) had BCVA of 6/36. 1 patient (5.8%) had BCVA of less than 6/60 
which was attributed to the associated complication. 
  
 TABLE 19: COMPLICATION 
POSTOPERATIVELY 
 
COMPLICATION 
CORNEAL EDEMA 
INCREASED IOP 
IOL DECENTRATION 
SUTURE EROSION 
CYSTOID MACULAR 
EDEMA 
RETINAL DETACHMENT
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0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
CE GL
PROFILE 6 WEEKS 
IN THE BAG 
PCIOL 
CILIARY 
SULCUS IOL 
SFIOL
0 0 
0 0 
0 0 
0 0 
0 1 
 
0 0 
ID SE CME RD
PCIOL
CIL SUL IOL
SFIOL
 
1 
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No complications were seen in patients with in the bag PCIOL group. 
In ciliary sulcus fixation IOL group, 1 case (10%) developed cystoid 
macular oedema. 
In SFIOL group, 1 patient (5.8%) had corneal oedema, 1 patient (5.8%) 
developed CME and 1 patient (5.8%) developed retinal detachment. 
 
  
 DISCUSSION 
A large number of aphakic patients opt for secondary IOL implantation 
because of intolerance to contact lens and/or spectacle correction. 
Various designs and fixation sites have been introduced for the correction 
of aphakia. But the posterior chamber IOL has become clearly the treatment of 
choice these days. 
In our study, 30 cases presented to our outpatient department with 
monocular aphakia and were treated surgically with secondary posterior 
chamber IOL implantation. 17 cases underwent scleral fixation IOL who had 
totally deficient posterior capsule. 10 cases had partial presence of posterior 
capsule and were implanted IOL in the ciliary sulcus. 3 cases had intact 
posterior capsule and were implanted within the bag posterior chamber IOL. 
The mean follow up of these patients was 6 weeks. 25 cases (83%) had a 
BCVA of 6/9 and above after 6 weeks post operatively. 4 cases (13%) had a 
BCVA of 6/36 or less. 1 cases (3%) had persistent corneal oedema even with 
treatment. 
2 cases (7%) developed cystoid macular oedema of which 1 case had 
underwent ciliary sulcus fixation IOL and another patient was treated with 
SFIOL. Both the cases were treated for CME and BCVA was 6/36. 
1 case (3%) had developed RD 1 month postoperatively and underwent RD 
surgery. This patient had undergone SFIOL and the BCVA after 6 weeks 
postoperatively was 2/60. 
 No complications were noted in cases that underwent secondary PCIOL 
implantation. 
IOL decentration was noted in 1 case of SFIOL group on 1st postoperative 
day and was taken up for surgery for repositioning of IOL on the next day. 
Hyphema was observed in 1 case who had undergone SFIOL 
implantation. It resolved spontaneously within 1 week. The same case had 
increase IOP for 1 week and was controlled with anti glaucoma drugs. 
SK was observed in 4 cases (18%) which resolved with time and did not affect 
visual acuity. 
Anterior uveitis was seen in 4 cases (13%), 2 cases with ciliary sulcus 
fixation and 2 cases with SFIOL implantation. These cases were treated with 
steroids and cycloplegics. Among 4 cases, 2 of them developed CME 6 weeks 
postoperatively affecting visual acuity. 
COMPARISON WITH PREVIOUS STUDIES 
1. Mazhry and Kadri did a prospective study of 45 patients over a period of 
5 years from October 1995 to November 2000. The study was to evaluate 
secondary PCIOL implantation. In this study, intact PCIOL was 
implanted in 6 eyes, 11 eyes were treated with capsulotomy and 
implantation of IOL, 3 eyes underwent synechiolysis and IOL 
implantation, transscleral IOL fixation in 26 eyes, IOL retrieval and 
fixation of dislocated IOL in 4 eyes. Average visual acuity was in the 
range of 6/9-6/12. The most common complication was glaucoma (8 
 cases) followed by vitreous haemorrhage (4 cases with transscleral 
fixation) and hyphema (2 cases).  
In our study, 83% had BCVA of 6/9 and above. Hyphema and 
glaucoma was seen in 1 case which was treated. No vitreous haemorrhage 
was observed in our study. 
2. Siva Charan did a retrospective study of 100 of non sutured secondary 
PCIOL implantation. In his study, 85% of patients developed good visual 
acuity in immediate postoperative period (up to 6/24). 15% patients had 
visual acuity less than 6/24. Most common immediate postoperative 
complication was anterior chamber reaction (19 cases). 8 cases developed 
corneal oedema. 5 cases had SK, 1 case developed choroidal detachment, 
2 cases had hyphema, vitreous haemorrhage was seen in 2 cases and 
fibrous membrane was seen in 9 cases. 
In our study, in non sutured PCIOL group most common 
complication in postoperative period was anterior chamber reaction 
(15%) and SK (15%). 
No hyphema or vitreous haemorrhage noted in our study. 1 case 
developed CME, who had BCVA of 6/36. 
3. Ghaeseminejad AK and Ahmadieh H reported the outcomes of 
transscleral fixation of PCIOL in 18 patients by a retrospective study. 
Postoperatively 9 cases (50%) had BCVA of  ≥ 20/40 and 9 cases (50%) 
had a BCVA of  ≤ 20/40.  Early postoperative complications like uveitis 
 were seen in 3 cases (16.7%) which improved with steroid treatment. 
Vitreous haemorrhage was seen in 2 cases (11.1%) which resolved 
spontaneously. Redislocation of IOL was seen in   2 cases (11.1%). 
Retinal detachment developed in 1 patient (5.6%). 1 case (5.6%) had 
significant IOL tilting. 
In our study anterior uveitis was seen in 4 cases (13%) which improved 
with treatment. Retinal detachment developed in 1 patient (3.3%) and was 
treated surgically. No vitreous haemorrhage and redislocation of  IOL 
was noted. 
4. Singh PG & Tripathy SK retrospectively studied 21 patients who 
underwent scleral fixation of IOL. 77% of patients achieved BCVA of 
6/18 and above postoperatively. 1 case (4.5%) had intra operative 
vitreous haemorrhage. Early post operative complications like transient 
corneal oedema were seen in 13 cases (59%). IOL decentration in 
3(13.6%).1 case (4.5%) was seen to have hyphema and fibrinous reaction 
is seen in 2 cases (9%). Corneal oedema in 2 eyes (9%) and optic capture 
in 1 eye (4.5%). 
In our study late postoperative complications was seen in 1 patient (3.3%) 
with corneal oedema. No suture exposure was seen in 6 weeks post 
operatively and no pupillary capture. 
 
 
 SUMMARY 
A prospective clinical study was conducted in Coimbatore medical 
college hospital which included 30 monocular aphakia patients who presented 
to our outpatient department.  These patients were treated surgically with 
secondary intraocular lens implantation in the posterior chamber. Depending on 
the capsular status, 17 cases were treated with scleral fixation of intraocular lens 
who had no capsular remnants. 10 cases underwent ciliary sulcus fixation of 
intraocular lens who had partial capsular remnants and 3 cases had intact 
posterior capsule and underwent in the bag PCIOL implantation. 
 These patients were followed up for a period of 6 weeks post operatively 
and BCVA with Snellen’s distance visual acuity chart was noted. Complications 
were also noted in the postoperative period. 
The results concluded that secondary intraocular lens implantation in the 
posterior chamber was a safe and effective procedure with a success rate of 
86.6%. Post operatively minor complications like striate keratopathy was seen 
in 4 cases which resolved within 1 week. Anterior uveitis was seen in 4 cases 
(13%) after 6 weeks 2 cases developed cystoid macular oedema and BCVA was 
6/36 in both these patients. 
1 patient (3.3%) developed hyphema and increased IOP which resolved 
with treatment. 1 patient had persistent corneal oedema in spite of treatment 6 
weeks postoperatively and had BCVA of 6/36. 
 1 patient (3.3%) was seen with IOL decentration on 1st postoperative day 
and  was taken up for surgery on next day for repositioning IOL. 1 patient 
(3.3%) developed retinal detachment after 6 weeks and was treated surgically 
for retinal detachment and had BCVA of 2/60. 
No complications were noted in patients with in the bag PCIOL 
implantation. This may be due to the disparity in number of patients in the three 
groups.  
A large prospective randomised clinical trial is required to determine the 
small differences in visual outcome and complication rate. 
 
 
 
 
 
 
 
 
 
 
 
  
 CONCLUSION 
In this study, secondary intraocular lens implantation in the posterior 
chamber was found to have the following outcome: 
1. Secondary intraocular lens implantation in the posterior chamber was 
a safe and effective method of correcting aphakia with a better visual 
outcome. 
2. It avoids the disadvantages associated with spectacles and contact lens 
usage like aniesokonia etc. 
3. Secondary intraocular lens implantation in the posterior chamber is 
superior to ACIOLs and iris fixated IOLs as it decreases the 
complications like bullous keratopathy, UGH syndrome, iritis, CME 
etc. 
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 PROFORMA 
CLINICAL STUDY OF SECONDARY INTRAOCULAR LENS 
IMPLANTATION 
1. Name: 
2. Age: 
3. Sex: 
4. IP number: 
5. Address: 
6. Date of Admission: 
7. Date of Surgery: 
8. Date of Discharge: 
9. Presenting Complaints: 
           Diminution of vision: 
           Duration: 
           Other complaints: 
10. Past History: 
    H/o diabetes mellitus 
    H/o hypertension 
    H/o trauma 
    H/o heart disease 
    H/o bronchial asthma 
    H/o any other systemic illness 
11. Previous Surgical History: 
     Indication: 
     Surgical Procedure Done: 
12. Preoperative visual acuity: 
     UCVA:    BCVA: 
13. Preoperative Ocular Examination: 
 Facial symmetry:  
      RE   LE 
Extraocular movements 
Eyelids 
Conjunctiva 
Cornea 
Anterior chamber 
Iris 
 Pupils 
Lens 
Presence of PC or 
  Anterior capsular remnants   
Fundus  
IOP      
14. Diagnosis:                      RE                       LE 
15. IOL Power Calculation (SRK formula) 
K1 reading 
K2 reading 
Axial length 
IOL power 
16. Surgery: 
Name of the Surgeon: 
Operative Procedure done: 
17. Intraoperative Complications 
Descemets Membrane Tear 
Vitreous Haemorrhage 
Retinal Detachment 
Others  
18. Post Operative Evaluation 
a. Day 1: 
Wound: 
Cornea: 
Anterior Chamber: 
Pupil: 
IOL: 
BCVA: 
b. 1st week 
Wound: 
         Cornea: 
         Anterior Chamber: 
Pupil: 
IOL: 
BCVA: 
c. 1 week 
         Wound: 
          Cornea: 
         Anterior Chamber: 
         Pupil: 
         IOL: 
         BCVA: 
d. 6 weeks 
Wound: 
Cornea: 
Anterior Chamber: 
Pupil: 
IOL: 
BCVA: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 INFORMED CONSENT 
 
 
I agree to undergo intraocular lens implantation in the right eye/left eye 
under local anesthesia. I have been informed about the technique and 
complications of the procedure. 
 
Date:  
Place:                                                                              Patients signature/  
                                                                                        Thumb impression                         
 
  
 KEY TO MATER CHART 
M   –  MALE 
F   –  FEMALE 
RE   –  RIGHT EYE 
LE   –  LEFT EYE 
BCVA – BEST CORRECTED VISUAL ACUITY 
AL   –  AXIAL LENGTH 
CSIOL  –  CILIARY SULCUS FIXATION IOL 
SFIOL  –  SCLERAL FIXATION IOL 
PCIOL  –  POSTERIOR CHAMBER IN THE BAG IOL 
AU   –  ANTERIOR UVEITIS 
CE   –  CORNEAL EDEMA 
SK   –  STRIATE KERATOPATHY 
ID   –  IOL DECENTRATION 
HY   –  HYPHEMA 
GL     –  GLAUCOMA 
CME   –  CYSTOID MACULAR EDEMA 
RD   –  RETINAL DETACHMENT 
                    
 
 
 
  
 MASTER CHART 
 
 
 
 
 
 
